# Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

> **NCT07516886** · — · RECRUITING · sponsor: **Lithuanian University of Health Sciences** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer (Post Prostatectomy)
- Prostate Cancer (Adenocarcinoma)
- Prostate Cancer (Diagnosis)
- Prostate Specific Antigen
- Radical Prostatectomy

## Interventions

- **PROCEDURE:** Radical Prostatectomy

## Key facts

- **NCT ID:** NCT07516886
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-22
- **Primary completion:** 2039-07
- **Final completion:** 2039-07
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516886, "Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07516886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*